Adult gliomas are a major cause of morbidity in the United States. Many patients with glioma will survive for years with extensive language, motor, and cognitive disabilities that impact the quality of their lives and ability to return to work. This has shifted the need for research and clinical questions to address not only survival, but also quality of life and functional outcomes.
Our goal is to improve patient outcome and quality of life by better understanding the neurobiology of cognitive recovery. We take an interdisciplinary approach to studying this question by combining molecular- and systems-level approaches with clinical research.